The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy

Pharmacology & Therapeutics
George E Billman

Abstract

The activation of cardiac cell membrane ATP-sensitive potassium channels during myocardial ischemia promotes potassium efflux, reductions in action potential duration, and heterogeneities in repolarization, thereby creating a substrate for re-entrant arrhythmias. Drugs that block this channel should be particularly effective anti-arrhythmic agents. Indeed, non-selective ATP-sensitive potassium channel antagonists, (e.g., glibenclamide) can prevent arrhythmias associated with myocardial ischemia. However, these non-selective antagonists have important non-cardiac actions that promote insulin release and hypoglycemia (pancreatic beta-cells), reduce coronary blood flow (vascular smooth muscle cells), prevent ischemia preconditioning (cardiac mitochondrial channels) and depress cardiac contractile function. The ATP-sensitive potassium channel consists of a pore forming inward rectifying potassium channel (Kir6.1 or Kir6.2) and a regulatory subunit (sulfonylurea receptors, SUR1, SUR2A &SUR2B). The Kir6.2/SUR2A combination appears to be preferentially expressed on cardiac cell membranes. As such, it should be possible to develop agents selective for cardiac sarcolemmal ATP-sensitive potassium channels. The novel compounds HMR 1883 (o...Continue Reading

References

Jan 1, 1979·The American Journal of Cardiology·L H OpieW F Lubbe
Nov 1, 1978·The American Journal of Physiology·L M Hondeghem, C L Cotner
Jan 1, 1977·The American Journal of Physiology·E E RauG A Langer
Jun 1, 1977·The American Journal of Physiology·K I ShineN Ricchiuti
Aug 1, 1992·British Journal of Pharmacology·E Ruiz PetrichO F Schanne
Mar 1, 1990·Journal of Cardiovascular Pharmacology·L ChiB R Lucchesi
Dec 1, 1991·The American Journal of Physiology·C G Nichols, W J Lederer
Sep 1, 1991·The American Journal of Physiology·N DeutschJ N Weiss
Aug 1, 1991·Pflügers Archiv : European journal of physiology·K BenndorfH Hirche
Aug 1, 1990·Naunyn-Schmiedeberg's Archives of Pharmacology·J K SmallwoodM I Steinberg
Mar 1, 1987·Circulation·L M Hondeghem
Jan 1, 1988·Journal of Cardiovascular Pharmacology·M R Goldberg
Aug 1, 1989·Journal of Molecular and Cellular Cardiology·C D WollebenP K Siegl
Apr 12, 1989·European Journal of Pharmacology·R D Kempsford, B J Hawgood
Apr 1, 1989·Circulation·R F Gillum
Jul 1, 1988·Pflügers Archiv : European journal of physiology·I Findlay

❮ Previous
Next ❯

Citations

Oct 18, 2011·Annals of Biomedical Engineering·Jessica Ka-Yan LawMansun Chan
Aug 18, 2012·Antioxidants & Redox Signaling·Nitin T Aggarwal, Jonathan C Makielski
Jul 14, 2010·Cardiovascular Research·David A Brown, Brian O'Rourke
Dec 14, 2011·Diabetes, Obesity & Metabolism·S SeinoT Shibasaki
Aug 2, 2012·Molecular Pharmacology·Daniela Ponce-BalbuenaJosé A Sánchez-Chapula
Jul 5, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Joshua M LaderGregory E Morley
Jul 29, 2010·Physiological Reviews·Thomas P FlaggColin G Nichols
Aug 12, 2009·Critical Care : the Official Journal of the Critical Care Forum·Pierre Asfar, Peter Radermacher
Feb 25, 2014·Current Diabetes Reports·Peter M Thulé, Guillermo Umpierrez
Dec 20, 2012·Oxidative Medicine and Cellular Longevity·Xiaolong QiJunjie Xiao
Jun 1, 2013·Cardiology and Therapy·Eric S Williams, Mohan N Viswanathan
Feb 2, 2011·Journal of Cardiovascular Pharmacology·A Shea HatcherHugh Clements-Jewery
Oct 1, 2014·Journal of Molecular and Cellular Cardiology·Soroosh Solhjoo, Brian O'Rourke
Sep 3, 2011·Journal of Molecular and Cellular Cardiology·Christin ChaoHerbert Y Gaisano
Apr 26, 2011·Pharmacology & Therapeutics·Fadi G Akar, Brian O'Rourke
Sep 12, 2009·Journal of Molecular and Cellular Cardiology·Alexey V GlukhovColin G Nichols
Dec 19, 2015·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Michael BerginMarie-Claire Van Hout
Apr 30, 2013·Journal of Molecular and Cellular Cardiology·Alexey V GlukhovColin G Nichols
Nov 29, 2008·Progress in Biophysics and Molecular Biology·Stanley NattelLeif Carlsson
Jul 5, 2011·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Sandeep V PanditJosé Jalife
Sep 13, 2016·The Journal of Clinical Investigation·Tobias BruegmannPhilipp Sasse
Apr 7, 2017·Journal of Cardiovascular Pharmacology and Therapeutics·Laura A HundahlThomas Jespersen
Sep 28, 2017·Journal of Cardiovascular Pharmacology and Therapeutics·Kamalan JeevaratnamA John Camm
Dec 29, 2011·Circulation. Arrhythmia and Electrophysiology·Thomas P Flagg, Colin G Nichols
Oct 22, 2009·Circulation. Arrhythmia and Electrophysiology·Pamela K Mason, John P DiMarco
Jan 3, 2014·Circulation. Arrhythmia and Electrophysiology·Lufang ZhouBrian O'Rourke
Dec 15, 2015·Physiological Reviews·Monique N Foster, William A Coetzee
May 16, 2015·The Journal of Pharmacology and Experimental Therapeutics·Bukar UmaruStavros Topouzis
Apr 1, 2016·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Hussein N Rubaiy
Sep 28, 2017·Clinical and Experimental Pharmacology & Physiology·Shiraz AhmadChristopher L-H Huang
Dec 17, 2020·International Journal of Molecular Sciences·Xiaoan Wu, H Peter Larsson
Jul 15, 2017·Mechanisms of Ageing and Development·Alina ScridonPhilippe Chevalier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.